DAILY INNOVATION BRIEF by Maryanne Kane, Journalist
.jpg)
D A ILY INNOVATION BRIEF By Journalists Edward Kane & Marya nne Kane NEW DRUG THERAPY COULD EXPAND DOGS' LIVES Source: Brewster Kane San Francisco-based biotech Loyal is pioneering a drug that expands the lifespan of big dogs. Here's what we know: Loyal's medication called LOY-001 has just won conditional approval from the FDA, which means they have reason to believe it will be effective Designed to increase the lifespan of large dogs It also maintains the quality of their lives Drug should be fully approved and available by 2026 Now going through accelerated clinical trials Works by reducing the level of key growth hormone - insulin growth factor-1 (IGF-1) Why this matters: big dogs have shorter lifespans of 8 to 12 years as opposed to smaller breeds that average 10 to 15 years It's a long-acting injectable medication administered by a vet every 3 to 6 months Loyal has not specified the cost and ho